Oxford Biomedica plc (LON:OXB)
343.50
-2.50 (-0.72%)
Jun 6, 2025, 5:07 PM BST
Oxford Biomedica Revenue
In the year 2024, Oxford Biomedica had annual revenue of 128.80M GBP with 43.84% growth. Oxford Biomedica had revenue of 77.99M in the half year ending December 31, 2024, with 2.67% growth.
Revenue
128.80M
Revenue Growth
+43.84%
P/S Ratio
2.83
Revenue / Employee
151.53K
Employees
850
Market Cap
364.43M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 128.80M | 39.26M | 43.84% |
Dec 31, 2023 | 89.54M | -50.45M | -36.04% |
Dec 31, 2022 | 139.99M | -2.81M | -1.97% |
Dec 31, 2021 | 142.80M | 55.07M | 62.77% |
Dec 31, 2020 | 87.73M | 23.67M | 36.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Oxford Biomedica News
- 2 months ago - Oxford Biomedica plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Oxford Biomedica plc (OXBDF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Oxford Biomedica reports FY results; reaffirms medium-term guidance - Seeking Alpha
- 3 months ago - UK Stock Market News: Anglo American, Mony Group, Oxford Biomedica - The Armchair Trader
- 6 months ago - Small Cap Stocks: Oxford Biomedica, Mirriad, United Oil & Gas - The Armchair Trader
- 9 months ago - Half Year 2024 Oxford Biomedica PLC Earnings Call Transcript - GuruFocus
- 9 months ago - Oxford Biomedica plc (OXBDF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Three Quick Facts: Oxford Biomedica, Rightmove, Galliford Try - The Armchair Trader